Patient-reported outcome measures in phase III trials of LY2963016 insulin glargine and reference insulin glargine products: ELEMENT 1 and ELEMENT 2

Authors:

Perez-Nieves M, K Pollom R, Duan R, Kalirai S, Delozier A, Kaushik P and Ilag L

Publication type:

Journal article

Publication name:

Generics and Biosimilars Initiative Journal

Citation:

Perez-Nieves M, K Pollom R, Duan R, Kalirai S, Delozier A, Kaushik P and Ilag L. Patient-reported outcome measures in phase III trials of LY2963016 insulin glargine and reference insulin glargine products: ELEMENT 1 and ELEMENT 2. GaBI Journal. 2018; 7(2):56-62.

Link to publication ⟶

⟵ Back to Search Results